Citation 88344

DUAN,H: TAKAISHI,Y: MOMOTA,H: OHMOTO,Y: TAKI,T:. (2002). IMMUNOSUPPRESSIVE CONSTITUENTS FROM SAUSSUREA MEDUSA.. 59(1)

Citation Details

TitleIMMUNOSUPPRESSIVE CONSTITUENTS FROM SAUSSUREA MEDUSA.
AuthorsDUAN,H: TAKAISHI,Y: MOMOTA,H: OHMOTO,Y: TAKI,T:
Year2002
Volume59
Issue1

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (1)

Saussurea medusa (ASTERACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FOR
NoneNone
2Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
BICYCLO[3.3.0]-OCTANE,2-ALPHA-GUAICYL-4-OXO-6-ALPHA-CATECHYL-3-7-DIOXA:
None
3
TUMOR NECROSING FACTOR INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BICYCLO[3.3.0]-OCTANE,2-ALPHA-GUAICYL-4-OXO-6-ALPHA-CATECHYL-3-7-DIOXA:
EQUIVOCAL
4
CELL TRANSFORMATION REVERSAL INDUCTION
PHARMACOLOGY OF COMPOUND - IN VITRO
BICYCLO[3.3.0]-OCTANE,2-ALPHA-GUAICYL-4-OXO-6-ALPHA-CATECHYL-3-7-DIOXA:
WEAK ACTIVITY
5
INTERLEUKIN-8 PRODUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BICYCLO[3.3.0]-OCTANE,2-ALPHA-GUAICYL-4-OXO-6-ALPHA-CATECHYL-3-7-DIOXA:
INACTIVE
6
INTERLEUKIN-2 FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BICYCLO[3.3.0]-OCTANE,2-ALPHA-GUAICYL-4-OXO-6-ALPHA-CATECHYL-3-7-DIOXA:
ACTIVE
7
INTERLEUKIN-4 RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BICYCLO[3.3.0]-OCTANE,2-ALPHA-GUAICYL-4-OXO-6-ALPHA-CATECHYL-3-7-DIOXA:
WEAK ACTIVITY
8
INTERFERON-GAMMA SECRETION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BICYCLO[3.3.0]-OCTANE,2-ALPHA-GUAICYL-4-OXO-6-ALPHA-CATECHYL-3-7-DIOXA:
EQUIVOCAL
9Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
BICYCLO[3.3.0]-OCTANE,1-ALPHA-HYDROXY-2-ALPHA-4-ALPHA-GUAICYL-3-7-DIOXA:
None
10
TUMOR NECROSING FACTOR INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BICYCLO[3.3.0]-OCTANE,1-ALPHA-HYDROXY-2-ALPHA-4-ALPHA-GUAICYL-3-7-DIOXA:
EQUIVOCAL
11
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BICYCLO[3.3.0]-OCTANE,1-ALPHA-HYDROXY-2-ALPHA-4-ALPHA-GUAICYL-3-7-DIOXA:
EQUIVOCAL
12
INTERLEUKIN-8 PRODUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BICYCLO[3.3.0]-OCTANE,1-ALPHA-HYDROXY-2-ALPHA-4-ALPHA-GUAICYL-3-7-DIOXA:
INACTIVE
13
INTERLEUKIN-2 FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BICYCLO[3.3.0]-OCTANE,1-ALPHA-HYDROXY-2-ALPHA-4-ALPHA-GUAICYL-3-7-DIOXA:
WEAK ACTIVITY
14
INTERLEUKIN-4 RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BICYCLO[3.3.0]-OCTANE,1-ALPHA-HYDROXY-2-ALPHA-4-ALPHA-GUAICYL-3-7-DIOXA:
WEAK ACTIVITY
15
INTERFERON-GAMMA SECRETION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BICYCLO[3.3.0]-OCTANE,1-ALPHA-HYDROXY-2-ALPHA-4-ALPHA-GUAICYL-3-7-DIOXA:
WEAK ACTIVITY
16Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PHAEOPHORBIDE A,13-EPI:
None
17
TUMOR NECROSING FACTOR INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHAEOPHORBIDE A,13-EPI:
WEAK ACTIVITY
18
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHAEOPHORBIDE A,13-EPI:
WEAK ACTIVITY
19
INTERLEUKIN-8 PRODUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHAEOPHORBIDE A,13-EPI:
INACTIVE
20
INTERLEUKIN-2 FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHAEOPHORBIDE A,13-EPI:
ACTIVE
21
INTERLEUKIN-4 RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHAEOPHORBIDE A,13-EPI:
WEAK ACTIVITY
22
INTERFERON-GAMMA SECRETION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHAEOPHORBIDE A,13-EPI:
ACTIVE
23Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PHAEOPHORBIDE A,13-EPI: METHYL ESTER
None
24
TUMOR NECROSING FACTOR INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHAEOPHORBIDE A,13-EPI: METHYL ESTER
INACTIVE
25
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHAEOPHORBIDE A,13-EPI: METHYL ESTER
ACTIVE
26
INTERLEUKIN-8 PRODUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHAEOPHORBIDE A,13-EPI: METHYL ESTER
INACTIVE
27
INTERLEUKIN-2 FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHAEOPHORBIDE A,13-EPI: METHYL ESTER
INACTIVE
28
INTERLEUKIN-4 RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHAEOPHORBIDE A,13-EPI: METHYL ESTER
ACTIVE
29
INTERFERON-GAMMA SECRETION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHAEOPHORBIDE A,13-EPI: METHYL ESTER
EQUIVOCAL
30Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
MEGASTIGM-7-EN-9-ONE,3-BETA-HYDROXY-5-ALPHA-6-ALPHA-EPOXY:
None
31Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
LIRIORESINOL B
None
32
TUMOR NECROSING FACTOR INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LIRIORESINOL B
ACTIVE
33
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LIRIORESINOL B
ACTIVE
34
INTERLEUKIN-8 PRODUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LIRIORESINOL B
ACTIVE
35
INTERLEUKIN-2 FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LIRIORESINOL B
STRONG ACTIVITY
36
INTERLEUKIN-4 RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LIRIORESINOL B
STRONG ACTIVITY
37
INTERFERON-GAMMA SECRETION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LIRIORESINOL B
ACTIVE
38Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
PINORESINOL,(+):
None
39
TUMOR NECROSING FACTOR INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PINORESINOL,(+):
ACTIVE
40
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PINORESINOL,(+):
ACTIVE
41
INTERLEUKIN-8 PRODUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PINORESINOL,(+):
ACTIVE
42
INTERLEUKIN-2 FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PINORESINOL,(+):
STRONG ACTIVITY
43
INTERLEUKIN-4 RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PINORESINOL,(+):
STRONG ACTIVITY
44
INTERFERON-GAMMA SECRETION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PINORESINOL,(+):
ACTIVE
45Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
MEDIORESINOL,(+):
None
46
TUMOR NECROSING FACTOR INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
MEDIORESINOL,(+):
EQUIVOCAL
47
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
MEDIORESINOL,(+):
WEAK ACTIVITY
48
INTERLEUKIN-8 PRODUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
MEDIORESINOL,(+):
INACTIVE
49
INTERLEUKIN-2 FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
MEDIORESINOL,(+):
ACTIVE
50
INTERLEUKIN-4 RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
MEDIORESINOL,(+):
ACTIVE
51
INTERFERON-GAMMA SECRETION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
MEDIORESINOL,(+):
ACTIVE
52Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
MATAIRESINOL
None
53Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
ARCTIGENIN
None
54
TUMOR NECROSING FACTOR INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
ARCTIGENIN
ACTIVE
55
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
ARCTIGENIN
WEAK ACTIVITY
56
INTERLEUKIN-8 PRODUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
ARCTIGENIN
INACTIVE
57
INTERLEUKIN-2 FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
ARCTIGENIN
WEAK ACTIVITY
58
INTERLEUKIN-4 RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
ARCTIGENIN
ACTIVE
59
INTERFERON-GAMMA SECRETION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
ARCTIGENIN
ACTIVE
60Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
ARCTIIN
None
61
TUMOR NECROSING FACTOR INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
ARCTIIN
INACTIVE
62
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
ARCTIIN
INACTIVE
63
INTERLEUKIN-8 PRODUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
ARCTIIN
ACTIVE
64
INTERLEUKIN-2 FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
ARCTIIN
INACTIVE
65
INTERLEUKIN-4 RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
ARCTIIN
WEAK ACTIVITY
66
INTERFERON-GAMMA SECRETION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
ARCTIIN
WEAK ACTIVITY
67Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
BERCHEMOL,(-):
None
68
TUMOR NECROSING FACTOR INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BERCHEMOL,(-):
INACTIVE
69
INTERLEUKIN-8 PRODUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BERCHEMOL,(-):
WEAK ACTIVITY
70
INTERLEUKIN-8 PRODUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BERCHEMOL,(-):
WEAK ACTIVITY
71
INTERLEUKIN-2 FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BERCHEMOL,(-):
WEAK ACTIVITY
72
INTERLEUKIN-4 RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BERCHEMOL,(-):
WEAK ACTIVITY
73
INTERFERON-GAMMA SECRETION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
BERCHEMOL,(-):
WEAK ACTIVITY
74Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
LARICIRESINOL
None
75
TUMOR NECROSING FACTOR INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LARICIRESINOL
WEAK ACTIVITY
76
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LARICIRESINOL
ACTIVE
77
INTERLEUKIN-8 PRODUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LARICIRESINOL
ACTIVE
78
INTERLEUKIN-2 FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LARICIRESINOL
STRONG ACTIVITY
79
INTERLEUKIN-4 RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LARICIRESINOL
STRONG ACTIVITY
80
INTERFERON-GAMMA SECRETION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LARICIRESINOL
ACTIVE
81Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
PINORESINOL,EPI:
None
82
TUMOR NECROSING FACTOR INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PINORESINOL,EPI:
EQUIVOCAL
83
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PINORESINOL,EPI:
EQUIVOCAL
84
INTERLEUKIN-8 PRODUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PINORESINOL,EPI:
INACTIVE
85
INTERLEUKIN-2 FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PINORESINOL,EPI:
WEAK ACTIVITY
86
INTERLEUKIN-4 RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PINORESINOL,EPI:
WEAK ACTIVITY
87
INTERFERON-GAMMA SECRETION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PINORESINOL,EPI:
ACTIVE
88Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
LARICIRESINOL,ISO: SECO:
None
89Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
PHAEOPHORBIDE A
None
90Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
PHAEOPHORBIDE A,METHYL:
None
91
TUMOR NECROSING FACTOR INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHAEOPHORBIDE A,METHYL:
INACTIVE
92
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHAEOPHORBIDE A,METHYL:
WEAK ACTIVITY
93
INTERLEUKIN-8 PRODUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHAEOPHORBIDE A,METHYL:
INACTIVE
94
INTERLEUKIN-2 FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHAEOPHORBIDE A,METHYL:
INACTIVE
95
INTERLEUKIN-4 RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHAEOPHORBIDE A,METHYL:
ACTIVE
96
INTERFERON-GAMMA SECRETION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHAEOPHORBIDE A,METHYL:
EQUIVOCAL
97Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
PHAEOPHORBIDE A,METHYL-13(2)-ALPHA-HYDROXY:
None
98Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
PHEOPHYTIN A
None
99
TUMOR NECROSING FACTOR INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHEOPHYTIN A
INACTIVE
100
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHEOPHYTIN A
EQUIVOCAL
101
INTERLEUKIN-8 PRODUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHEOPHYTIN A
ACTIVE
102
INTERLEUKIN-2 FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHEOPHYTIN A
WEAK ACTIVITY
103
INTERLEUKIN-4 RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHEOPHYTIN A
WEAK ACTIVITY
104
INTERFERON-GAMMA SECRETION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHEOPHYTIN A
WEAK ACTIVITY
105Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
PHEOPHYTIN B
None
106Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
PHEOPHYTIN A,13(2)-BETA-HYDROXY:
None
107
TUMOR NECROSING FACTOR INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHEOPHYTIN A,13(2)-BETA-HYDROXY:
INACTIVE
108
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHEOPHYTIN A,13(2)-BETA-HYDROXY:
WEAK ACTIVITY
109
INTERLEUKIN-8 PRODUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHEOPHYTIN A,13(2)-BETA-HYDROXY:
WEAK ACTIVITY
110
INTERLEUKIN-2 FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHEOPHYTIN A,13(2)-BETA-HYDROXY:
WEAK ACTIVITY
111
INTERLEUKIN-4 RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHEOPHYTIN A,13(2)-BETA-HYDROXY:
INACTIVE
112
INTERFERON-GAMMA SECRETION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHEOPHYTIN A,13(2)-BETA-HYDROXY:
EQUIVOCAL
113Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
PHEOPHYTIN A,13(2)-ALPHA-HYDROXY:
None
114
TUMOR NECROSING FACTOR INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHEOPHYTIN A,13(2)-ALPHA-HYDROXY:
INACTIVE
115
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHEOPHYTIN A,13(2)-ALPHA-HYDROXY:
WEAK ACTIVITY
116
INTERLEUKIN-8 PRODUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHEOPHYTIN A,13(2)-ALPHA-HYDROXY:
INACTIVE
117
INTERLEUKIN-2 FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHEOPHYTIN A,13(2)-ALPHA-HYDROXY:
INACTIVE
118
INTERLEUKIN-4 RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHEOPHYTIN A,13(2)-ALPHA-HYDROXY:
EQUIVOCAL
119
INTERFERON-GAMMA SECRETION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PHEOPHYTIN A,13(2)-ALPHA-HYDROXY:
EQUIVOCAL
120Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
LOLIOLIDE
None
121
TUMOR NECROSING FACTOR INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LOLIOLIDE
INACTIVE
122
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LOLIOLIDE
INACTIVE
123
INTERLEUKIN-8 PRODUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LOLIOLIDE
WEAK ACTIVITY
124
INTERLEUKIN-2 FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LOLIOLIDE
INACTIVE
125
INTERLEUKIN-4 RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LOLIOLIDE
EQUIVOCAL
126
INTERFERON-GAMMA SECRETION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
LOLIOLIDE
WEAK ACTIVITY
127Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
COSTUSLACTONE,DEHYDRO: 11-BETA(H)-11-13-DIHYDRO: 3-ALPHA-8-ALPHA-DIHYDROXY:
None
128
TUMOR NECROSING FACTOR INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
COSTUSLACTONE,DEHYDRO: 11-BETA(H)-11-13-DIHYDRO: 3-ALPHA-8-ALPHA-DIHYDROXY:
INACTIVE
129
INTERLEUKIN-1-BETA-SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
COSTUSLACTONE,DEHYDRO: 11-BETA(H)-11-13-DIHYDRO: 3-ALPHA-8-ALPHA-DIHYDROXY:
EQUIVOCAL
130
INTERLEUKIN-8 PRODUCTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
COSTUSLACTONE,DEHYDRO: 11-BETA(H)-11-13-DIHYDRO: 3-ALPHA-8-ALPHA-DIHYDROXY:
WEAK ACTIVITY
131
INTERLEUKIN-2 FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
COSTUSLACTONE,DEHYDRO: 11-BETA(H)-11-13-DIHYDRO: 3-ALPHA-8-ALPHA-DIHYDROXY:
WEAK ACTIVITY
132
INTERLEUKIN-4 RELEASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
COSTUSLACTONE,DEHYDRO: 11-BETA(H)-11-13-DIHYDRO: 3-ALPHA-8-ALPHA-DIHYDROXY:
WEAK ACTIVITY
133
INTERFERON-GAMMA SECRETION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
COSTUSLACTONE,DEHYDRO: 11-BETA(H)-11-13-DIHYDRO: 3-ALPHA-8-ALPHA-DIHYDROXY:
EQUIVOCAL
Show SPARQL Queries (1)